339 related articles for article (PubMed ID: 9482467)
1. Patent protection for medical technologies: why some and not others?
Melzer D
Lancet; 1998 Feb; 351(9101):518-9. PubMed ID: 9482467
[No Abstract] [Full Text] [Related]
2. Preparing effective experimental data for pharmaceutical patent applications from US and Japanese perspectives.
Altman D; Sweeney C; Yasui T
Pharm Pat Anal; 2014 Sep; 3(5):469-73. PubMed ID: 25374314
[No Abstract] [Full Text] [Related]
3. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
McCabe AR
Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844
[No Abstract] [Full Text] [Related]
4. The federal preemption debate in pharmaceutical labeling product liability actions.
Gross JM; Curry JA
Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
[No Abstract] [Full Text] [Related]
5. The application of the patent laws to the drug approval process.
Coggio BD; Cerrito FD
Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669
[No Abstract] [Full Text] [Related]
6. The ongoing regulation of generic drugs.
Frank RG
N Engl J Med; 2007 Nov; 357(20):1993-6. PubMed ID: 18003956
[No Abstract] [Full Text] [Related]
7. Old drugs, new uses: solving a Hatch-Waxman patent predicament.
McPhie DC
Food Drug Law J; 2004; 59(1):155-68. PubMed ID: 15190929
[No Abstract] [Full Text] [Related]
8. A cheat sheet to navigate the complex maze of exclusivities in the United States.
Peng B; Tomas MC
Pharm Pat Anal; 2014 Jul; 3(4):339-43. PubMed ID: 25291306
[No Abstract] [Full Text] [Related]
9. The consumer welfare implications of governmental policies and firm strategy in markets for medicines.
Chatterjee C; Kubo K; Pingali V
J Health Econ; 2015 Dec; 44():255-73. PubMed ID: 26581076
[TBL] [Abstract][Full Text] [Related]
10. U.S. patent law. Case probes what's fair game in the search for new drugs.
Kintisch E
Science; 2005 Apr; 308(5719):174. PubMed ID: 15821048
[No Abstract] [Full Text] [Related]
11. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers.
Soehnge H
Food Drug Law J; 2003; 58(1):51-80. PubMed ID: 12739584
[No Abstract] [Full Text] [Related]
12. Regulators need to regulate. For health and safety issues, the nation needs watchdogs to be on guard.
May D
Mod Healthc; 2010 Mar; 40(9):16. PubMed ID: 20344831
[No Abstract] [Full Text] [Related]
13. Injecting Safety into Supplements - Modernizing the Dietary Supplement Law.
Cohen PA; Bass S
N Engl J Med; 2019 Dec; 381(25):2387-2389. PubMed ID: 31851798
[No Abstract] [Full Text] [Related]
14. Using a drug-safety tool to prevent competition.
Sarpatwari A; Avorn J; Kesselheim AS
N Engl J Med; 2014 Apr; 370(16):1476-8. PubMed ID: 24738666
[No Abstract] [Full Text] [Related]
15. Understanding the Rewards of Successful Drug Development - Thinking Inside the Box.
Khullar D; Ohn JA; Trusheim M; Bach PB
N Engl J Med; 2020 Jan; 382(5):473-480. PubMed ID: 31995697
[No Abstract] [Full Text] [Related]
16. How Cuozzo will impact the interplay between post grant proceedings and Hatch-Waxman litigation.
Mishra N; Doody PA; Davé RS
Pharm Pat Anal; 2017 Jan; 6(1):9-15. PubMed ID: 28181455
[No Abstract] [Full Text] [Related]
17. On access and accountability--two Supreme Court rulings on generic drugs.
Boumil MM; Curfman GD
N Engl J Med; 2013 Aug; 369(8):696-7. PubMed ID: 23923990
[No Abstract] [Full Text] [Related]
18. EU court gets tough on patent extensions for combo products.
Waters H
Nat Med; 2012 Jan; 18(1):4. PubMed ID: 22227647
[No Abstract] [Full Text] [Related]
19. Pharmaceutical industry must take its medicine.
Macilwain C
Nature; 2011 Feb; 470(7333):141. PubMed ID: 21307893
[No Abstract] [Full Text] [Related]
20. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
Purnhagen KP
Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
